	Liver diseases, transaminases, and hepatobiliary-pancreatic cancer risk: a cohort and Mendelian randomisation study using data from UK Biobank. BMJ Open Gastroenterol Yuan Y, Jiang Y, Hu C, Wu D, Chen H, Tian Q, He R, Li T, Huang T, Jiang H, Zhong W, Chen Y, Jiang J, Zheng S, Chen R. PMID: 40645641 [PubMed - indexed for MEDLINE]
	Hepatocellular Carcinoma Surveillance and Survival in a Contemporary Asia-Pacific Cohort. JAMA Netw Open Lim RY, Koh B, Ng CH, Kulkarni AV, Liu K, Wijarnpreecha K, Kim BK, Muthiah MD, Lee SW, Zheng MH, Kawaguchi T, Takahashi H, Huang DQ, Liver Cancer Research Network. PMID: 40643909 [PubMed - indexed for MEDLINE]
	Preoperative Hepatic Augmentation Versus Transarterial Chemoembolization for Hepatocellular Carcinoma With Insufficient Remnant Liver Volume: A Systematic Review and Meta-Analysis. Cancer Med Li W, Li H, Kong Q, Teng F, Chen Z. PMID: 40642840 [PubMed - indexed for MEDLINE]
	Lenvatinib combined with anti-PD-1 antibodies plus locoregional treatment for initial unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a multicenter real-world study. BMC Cancer Chi QY, Liu QY, Wang SJ, Liu YD, Gao XD, Lin KY, Yang LF, Liu ZJ, Chi MH, Weng SG, Zeng YY, Zhang ZB. PMID: 40640796 [PubMed - indexed for MEDLINE]
	Unraveling the Causal Links Between Immune Traits and Hepatocellular Carcinoma: Insights From a Bi-Directional Mendelian Randomization Study. Turk J Gastroenterol Li J, Wang G, Xiang X, Wang J. PMID: 40636979 [PubMed - indexed for MEDLINE]
	Tracking cellular therapies to optimize homing against liver metastases. Front Immunol Purl MC, Shick A, Canter RJ, Judge SJ. PMID: 40636106 [PubMed - indexed for MEDLINE]
	Stereotactic body radiation therapy for liver metastases and primary liver tumors: treatment results and toxicity. Neoplasma Dobnikar N, Secerov Ermenc A, Grabec D, Jeromen Peressutti A, Korosec P, Zager Marcius V, Boc N, Ratosa I, Oblak I. PMID: 40635508 [PubMed - indexed for MEDLINE]
	Sustained Virological Response as a Surrogate Marker for Mortality, Decompensated Cirrhosis, or Hepatocellular Carcinoma in People With Chronic Hepatitis C Virus Infection Treated With Direct-Acting Antivirals: Protocol for a Bayesian and Causal Mediation Analysis. JMIR Res Protoc Gurusamy KS, Gluud C. PMID: 40633094 [PubMed - indexed for MEDLINE]
	The evolving concept of conversion surgery for upfront unresectable upper gastrointestinal and hepato-pancreato-biliary cancers: comprehensive review. BJS Open Perri G, Engstrand J, Wright RD, Bronzwaer SFC, Kroese TE, Huang B, Acidi B, Vitale A, Tran Cao HS, van Hillegersberg R, Nilsson M, Sparrelid E, Katz MHG, Marchegiani G, Cillo U. PMID: 40631805 [PubMed - indexed for MEDLINE]
	Five-Gene Expression Formula Accurately Detects Hepatocellular Carcinoma Tumors. Biotechnol J Ansary Ogholbake A, Cheng Q. PMID: 40629990 [PubMed - indexed for MEDLINE]
	Impact of LI-RADS CT and MRI Ancillary Features on Diagnostic Performance: An Individual Participant Data Meta-Analysis. Radiology Abedrabbo N, Lam ET, McInnes MDF, Dawit H, Kadi D, van der Pol CB, Salameh JP, Levis B, Naringrekar H, Lerner E, Adamo RG, Alabousi M, Polikoff A, Furlan A, Tang A, Kierans AS, Singal AG, Arvind A, Alhasan A, Song B, Allen BC, Reiner CS, Clarke C, Ludwig DR, Diaz Telli F, Piñero F, Rosiak G, Jiang H, Kwon H, Wei H, Kang HJ, Joo I, Hwang JA, Min JH, Song JS, Wang J, Podgórska J, Eisenbrey JR, Bartnik K, Chen LD, Ronot M, Cerny M, Seo N, Rao SX, Cannella R, Choi SH, Kim SY, Fraum TJ, Wang W, Jeong WK, Jing X, Kim YY, Kang Z, Bashir MR, Costa AF. PMID: 40626878 [PubMed - indexed for MEDLINE]
	The Evolving Application of Radiation Segmentectomy for the Treatment of Hepatic Malignancy. Radiology Lewandowski RJ, Serhal M, Padia SA, Kim E, Brown DB, Tabori NE, Toskich BB. PMID: 40626876 [PubMed - indexed for MEDLINE]
	Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models. Gut Liver Desert R, Gianonne F, Saviano A, Hoshida Y, Heikenwälder M, Nahon P, Baumert TF. PMID: 40626281 [PubMed - indexed for MEDLINE]
	Matching-adjusted indirect comparison of tislelizumab plus lenvatinib versus sintilimab plus bevacizumab biosimilar as first-line treatment for unresectable hepatocellular carcinoma. Front Immunol Wang K, Liu C, Song X, Zhao N, Zheng X. PMID: 40625746 [PubMed - indexed for MEDLINE]
	Non-coding RNAs as key regulators in hepatitis B virus-related hepatocellular carcinoma. Front Immunol Ramalingam PS, Zhang L, Hussain MS, Khan G, Mawkili W, Hanbashi A, Gupta G, Balakrishnan P, Arumugam S. PMID: 40625740 [PubMed - indexed for MEDLINE]
	The safety and effectiveness of sintilimab versus camrelizumab, both plus targeted drugs, in advanced hepatocellular carcinoma. Front Immunol Zhao C, Zhu Q, Qian X, Fu Z, Zhang W, Wang Y. PMID: 40625737 [PubMed - indexed for MEDLINE]
	Clinical performance evaluation of a plasma dual-target methylation test for the detection of primary liver cancer: a multicenter study. Clin Epigenetics Xu Z, Chen W, Wei H, Tan K, Zhang L, Dong L, Liang W, Zhou X, Zhang T, Chen J, Peng C, Wang Z, Ye S, Ye Q. PMID: 40624654 [PubMed - indexed for MEDLINE]
	Efficacy and safety of ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma at specific anatomic sites of the liver: a systematic review and meta-analysis. BMC Gastroenterol Fu Y, Zhu Q, Zhao X, Lu J, Wang W. PMID: 40624629 [PubMed - indexed for MEDLINE]
	Multilayer perceptron deep learning radiomics model based on Gd-BOPTA MRI to identify vessels encapsulating tumor clusters in hepatocellular carcinoma: a multi-center study. Cancer Imaging Gu M, Zou W, Chen H, He R, Zhao X, Jia N, Liu W, Wang P. PMID: 40624579 [PubMed - indexed for MEDLINE]
	Identification and validation of MMP1 as a biomarker associated with mitochondrial oxidative stress in liver hepatocellular carcinoma. Sci Rep Wang Z, Zhou H, Zhang L, Liu X, Wang H. PMID: 40624187 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 72365

Page 1 of 3619



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy